Skip NavigationSkip to Content

Bridgehead Modifications of Englerin A Reduce TRPC4 Activity and Intravenous Toxicity but not Cell Growth Inhibition

  1. Author:
    Wu, Zhenhua
    Suppo, Jean-Simon
    Tumova, Sarka
    Strope, Jonathan
    Bravo, Fernando
    Moy, Melody
    Weinstein, Ethan S
    Peer, Cody J
    Figg, William D
    Chain, William J
    Echavarren, Antonio M
    Beech, David J
    Beutler,John
  2. Author Address

    Department of Chemistry & Biochemistry, University of Delaware, 163 The Green, Newark, Delaware 19716, United States., Institute of Chemical Research of Catalonia (ICIQ), 43007 Tarragona, Spain., School of Medicine, University of Leeds, Leeds LS2 9JT, U.K., Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892, United States., Molecular Targets Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, United States.,
    1. Year: 2020
    2. Date: Sep 10
    3. Epub Date: 2020 08 03
  1. Journal: ACS medicinal chemistry letters
    1. 11
    2. 9
    3. Pages: 1711-1716
  2. Type of Article: Article
  3. ISSN: 1948-5875
  1. Abstract:

    Modifications at the bridgehead position of englerin A were made to explore the effects of variation at this site on the molecule for biological activity, as judged by the NCI 60 screen, in which englerin A is highly potent and selective for renal cancer cells. Replacement of the isopropyl group by other, larger substituents yielded compounds which displayed excellent selectivity and potency comparable to the natural product. Selected compounds were also evaluated for their effect on the ion channel TRPC4 as well as for intravenous toxicity in mice, and these had lower potency in both assays compared to englerin A. Copyright © 2020 American Chemical Society.

    See More

External Sources

  1. DOI: 10.1021/acsmedchemlett.0c00186
  2. PMID: 32944138
  3. PMCID: PMC7488277
  4. WOS: 000571499500008

Library Notes

  1. Fiscal Year: FY2020-2021
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel